Lidocaine Cream 4% Recalled Due to Manufacturing Quality Deviations
Teligent Pharma is recalling all unexpired batches of Lidocaine Cream 4% (30-gram tubes) nationwide because the company is discontinuing its stability study program, a violation of manufacturing standards.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a manufacturing/procedural deviation (discontinued stability studies) rather than a confirmed product contamination or defect causing reported illness or injury. The hazard is regulatory/compliance-based rather than an immediate safety threat, making it a Moderate severity recall.
Plain-English summary
Teligent Pharma, Inc. is recalling Lidocaine Cream 4% in 30-gram tubes distributed by RUGBY LABORATORIES (NDC 0536-1281-28). The recall affects approximately 48,907 tubes distributed nationwide in the USA and Puerto Rico. All products within their expiration dates are included, covering batches 15722, 16274, 16947, and 17140, with expiration dates ranging from June 2022 through August 2023.
The recall is due to current Good Manufacturing Practice (cGMP) deviations. Specifically, the firm is discontinuing its stability study program, which is required to ensure drug safety and efficacy over time.
Patients currently using this product should consult their healthcare provider or pharmacist before discontinuing use. Those who have concerns about their specific batch should contact their pharmacy or healthcare provider for guidance.
The recalled product
- Product
- Lidocaine Cream 4%, Net Wt. 30 grams tube, Distributed by: RUGBY LABORATORIES, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC 0536-1281-28.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical anesthetic
- Hazard
- manufacturing-deviation
- stability-study-discontinuation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Batch: 15722
- Exp. 6/30/2022
- 16274
- Exp. 12/31/2022
- 16947
- Exp. 5/31/2023
- 17140
- Exp. 8/31/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27